Clinical Trial Detail

NCT ID NCT02348489
Title SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

Guadecitabine

Cytarabine

Azacitidine

Decitabine

Age Groups: adult

No variant requirements are available.